A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study

Abstract

The literature reported higher depression rates in psoriasis patients compared to the general population. Our study aimed to verify whether variability in depression prevalence was due to using different diagnostic tools. We also aimed to determine whether dysfunctional coping strategies might increase the depression burden. We assessed psoriasis severity by the Psoriasis Area Severity Index (PASI) and PSOdisk. We analyzed mental alterations of 120 outpatients by Hamilton Depression and Anxiety Rating Scales (HAM-D and HAM-A), Symptom Checklist-90-Revised (SCL-90-R), plus coping strategies and quality of life by Coping Orientation to Problems Experienced (COPE) Inventory and 36-Item Short Form Health Survey (SF-36). We divided our cohort into five subgroups from minimal to severe psoriasis using the PSOdisk total score. Depression prevalence varied according to the assessment criteria for specificity, frequency, and severity. Different mood disorders other than major depression emerged when we used DSM-IV-TR criteria. Correlation analysis of the criteria we used to diagnose depression or depressed mood indicated that a dysfunctional coping strategy was highly and positively correlated only in patients of the severe subgroup. Differently, a negative correlation emerged between the SF-36 Mental Summary Component (MSC) and behavioral disengagement, thus suggesting that psychopathological distress might induce patients with a marked/severe psoriasis to adopt dysfunctional coping strategies. Dermatologists are fundamental in detecting comorbid depression, referring psoriasis patients to mental health specialists to achieve adequate treatments, and preventing suicide risk.

Evaluating the Efficacy and Safety of Bimekizumab for Plaque Psoriasis and Psoriatic Arthritis: An Expert Consensus Panel Report

“…67,68 The reported percentage of psoriasis patients with depressive symptoms has varied from 9% to 55%, likely due to the use of different assessment criteria and study populations. 69 The link between psoriasis and depression has frequently been attributed to the disease being highly stigmatized due to the visible nature of psoriatic lesions. 70 However, newer theories indicate that inflammatory cytokines in psoriasis can cause physiologic and biochemical changes in the central nervous system, leading to symptoms of depression.…”

Matching between clinical examination and dermoscopy in patients with nail psoriasis: Should dermoscopy be used instead of clinical examination?

“…The clinical manifestations of nail psoriasis vary according to the compartment of the nail units involved, including nail discoloration, subungual hyperkeratosis, pitting, and onycholysis [ 9 ]. Nail psoriasis severely impacts the individual's quality of life and can interfere with professional and other activities [ 9 , 10 ]…”

The Prevalence of Depression and Acceptance Rate of Referral to Psychiatrist Among Psoriatic Patients in Saudi Arabia

“…A patient's perception of their disease severity, regardless of the objective extent of skin involvement, correlates with depression risk [6]. The percentage of psoriasis patients with depressive symptoms ranges from 9%-55% due to differences in assessment criteria and study populations [7]. Patients with psoriasis who fail to respond to treatment have higher rates of depression and anxiety [8].…”